insights_auto
Why is PTX down 3.03%?
Dive Deeperchevron_right
PTX:ASX
Prescient Therapeutics Ltd
A$0.064
arrow_downward
-3.03%(-0.0020) 1D
Oct 5, 3:23:42 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.07
High
A$0.07
Low
A$0.06
Mkt. cap
69.02M
Avg. vol.
1.19M
Volume
245.97K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
Open
A$0.07
High
A$0.07
Low
A$0.06
Mkt. cap
69.02M
Avg. vol.
1.19M
Volume
245.97K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
News stories
From web sources and news partners
Investing.com
·
20 minutes ago
S&P 500: 7,900 Still in Sight, but Rising Yields Raise the Risk
Moomoo
·
12 minutes ago
U.S. Futures Sink, European Stocks Up
Trefis
·
43 minutes ago
S&P 500 Stocks At 52-Week Highs: Friday’s Full List
VT Markets
·
1 hour ago
Week Ahead: Weak US Jobs Shift Fed Outlook as Gold, USD and S&P 500 React
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com